In support of a potential link between EV-mediated immune suppression and MM pathobiology, we observed that patients with high-risk cytogenetic alterations, particularly gain of chromosome 1q, exhibited significantly higher HLA-G expression at the mRNA level in malignant plasma cells. The gene discussed is HLA-G; the disease is Miyoshi myopathy.